October 23, 2021
1 min read

Eye rubbing, FDA approvals lead October ophthalmology coverage

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

The effect of eye rubbing in children and FDA approvals lead Healio/OSN coverage in October.

Read the best-performing articles below.

OCT study shows effect of eye rubbing in childrens corneas

An anterior segment OCT study showed that the corneas of children who frequently rub their eyes have abnormal epithelial thickness distribution, with thinning in the inferotemporal area on the dominant-hand side. Read more.

Tyrvaya nasal spray receives FDA approval for treatment of dry eye disease

The FDA approved Tyrvaya nasal spray for the treatment of signs and symptoms of dry eye disease, according to a press release from Oyster Point Pharma. Read more.

Dextenza receives FDA approval for ocular itching associated with allergic conjunctivitis

The FDA has approved a supplemental new drug application for Dextenza, adding ocular itching associated with allergic conjunctivitis to the drug’s current indications, according to a press release from Ocular Therapeutix. Read more.

Presbyopia-correcting drops could be temporary step before future surgery

NEW YORK — Presbyopia-correcting drops may be a good choice for patients who previously underwent corneal refractive surgery and can act as a temporizing measure until further surgery becomes necessary. Read more.

Concierge cataract surgery may provide answer to future financial, logistical challenges

NEW YORK — The future of cataract surgery in the U.S. may involve divergent pathways in order to accommodate increasingly common “add-ons” without devaluing the procedure as a whole. Read more.